CN Stock MarketDetailed Quotes

300147 Xiangxue Pharmaceutical

Watchlist
  • 14.36
  • +0.37+2.64%
Market Closed Nov 8 15:00 CST
9.50BMarket Cap-20602P/E (TTM)

Xiangxue Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-42.27%75.6M
-19.70%102.35M
-17.99%117.27M
-10.32%149.32M
-21.56%130.96M
-40.93%127.45M
-59.93%142.99M
-15.10%166.5M
1.30%166.96M
0.50%215.76M
Transactional financial assets
----
----
7,158.71%4M
----
----
----
-99.91%55.11K
-99.81%125.98K
-92.50%231.17K
1,509.86%75.89M
Notes receivable and accounts receivable
10.89%891.32M
10.98%862.15M
13.41%832.14M
16.45%793.8M
46.85%803.78M
-31.13%776.82M
-37.00%733.77M
-38.54%681.65M
-51.41%547.36M
2.42%1.13B
-Notes receivable
-73.72%39.76M
-66.29%48.7M
-33.32%87.45M
8.81%88.86M
5,546.15%151.28M
1,149.32%144.47M
--131.16M
555.27%81.66M
--2.68M
--11.56M
-Accounts receivable
30.51%851.57M
28.64%813.45M
23.58%744.69M
17.49%704.94M
19.80%652.5M
-43.36%632.35M
-48.26%602.61M
-45.29%599.99M
-51.65%544.68M
1.37%1.12B
Other receivables (including interest and dividends)
19.75%64.91M
7.21%59.55M
-20.76%51.78M
-31.28%52.55M
-23.80%54.21M
22.38%55.55M
-15.14%65.35M
-77.90%76.47M
-31.38%71.14M
-59.74%45.39M
-Dividend receivable
--22.44M
--22.44M
--22.44M
0.00%22.44M
----
----
----
--22.44M
----
----
-Other receivable
----
--37.11M
----
----
----
----
----
--54.03M
----
-46.51%45.39M
Advance payment
-4.51%21.63M
-26.83%21.78M
-30.12%27.21M
-55.08%24.55M
-54.42%22.65M
8.09%29.77M
-59.42%38.93M
-28.10%54.66M
-18.85%49.69M
-55.41%27.54M
Inventories
-16.63%420.98M
-5.75%462.58M
-19.71%407.6M
-11.94%411.3M
18.25%504.96M
-27.25%490.78M
-28.45%507.63M
-38.66%467.07M
-50.43%427.03M
-20.65%674.65M
Receivable financing
----
--0
----
-96.79%642.66K
-95.45%2.34M
-88.37%7.9M
-90.06%8.04M
-81.98%20.05M
-23.26%51.43M
-13.34%67.87M
Assets held for sale
8.07%314.7M
251.06%312.78M
168.80%311.56M
133.79%323.74M
128.40%291.2M
-12.36%89.1M
8.99%115.91M
-30.39%138.48M
-9.48%127.5M
-30.17%101.66M
Other current assets
-12.90%68.42M
-14.54%68.48M
-17.84%72.22M
-22.38%68.45M
-11.26%78.55M
-70.47%80.12M
-64.74%87.9M
-60.16%88.18M
-36.78%88.51M
111.72%271.35M
Total current assets
-1.65%1.86B
14.01%1.89B
7.24%1.82B
7.75%1.82B
23.45%1.89B
-36.45%1.66B
-41.34%1.7B
-45.13%1.69B
-42.67%1.53B
-3.32%2.61B
Non Current assets
Other equity investment
-2.76%86.53M
-2.76%86.53M
-2.76%86.53M
-2.76%86.53M
-10.10%88.98M
-10.10%88.98M
-10.10%88.98M
-10.10%88.98M
-67.33%98.98M
-62.36%98.98M
Other non-current financial assets
-36.25%29.29M
-18.50%38.58M
1.97%48.27M
1.89%48.24M
-14.69%45.95M
-13.96%47.33M
-15.39%47.34M
-16.10%47.35M
-49.86%53.86M
-48.81%55.01M
Investment real estate
----
----
----
----
----
----
----
----
----
11.84%245.3M
Long-term equity investment
-68.32%33.92M
-88.97%34.03M
-86.87%44.18M
-86.98%43.71M
-67.52%107.08M
178.97%308.47M
201.41%336.38M
192.43%335.7M
171.80%329.72M
-11.44%110.57M
Fixed assets
----
--3.28B
----
----
----
----
----
--3.6B
----
100.20%4B
Constru in process
----
--1.13B
----
----
----
----
----
--1.18B
----
-47.78%2B
Productive biological assets
14.64%616.77K
-3.87%648.91K
-3.04%609.25K
-3.24%560.59K
1.41%538K
-17.83%675K
-22.08%628.35K
-27.05%579.35K
-31.77%530.51K
7.32%821.5K
Intangible assets
-8.33%851.89M
-7.69%868.69M
-4.67%907.42M
-4.65%919.28M
-4.70%929.27M
-6.92%941.05M
-7.54%951.92M
-6.79%964.09M
-8.20%975.11M
-5.58%1.01B
Development expenditure
8.66%459.2M
8.32%450.44M
8.83%445.5M
8.33%436.49M
7.79%422.59M
0.85%415.85M
0.92%409.34M
1.89%402.93M
-5.60%392.07M
1.79%412.35M
Goodwill
0.00%199.72M
0.00%199.72M
0.00%199.72M
0.00%199.72M
0.00%199.72M
-25.09%199.72M
-25.09%199.72M
-25.09%199.72M
-68.13%199.72M
-57.45%266.6M
Long deferred expense
-8.51%34.2M
-3.73%36.45M
2.80%38.19M
6.86%40.31M
9.38%37.38M
28.62%37.86M
18.03%37.15M
10.76%37.72M
-5.96%34.17M
-20.97%29.43M
Deferred tax assets
-5.12%25.21M
-0.34%28.4M
8.94%28.72M
-14.79%28.42M
74.71%26.57M
58.43%28.5M
36.59%26.37M
72.14%33.35M
-24.00%15.21M
-11.66%17.99M
Usufruct assets
36.45%31.91M
39.86%33.94M
39.31%35.35M
36.55%36.16M
1,313.63%23.39M
529.46%24.27M
458.67%25.38M
399.97%26.48M
-1.32%1.65M
59.53%3.86M
Other non current assets
-30.31%23.76M
11.90%38.48M
31.86%38.87M
6.87%33.08M
-56.13%34.1M
-60.70%34.39M
-53.26%29.48M
-55.45%30.95M
-61.42%77.73M
-58.00%87.51M
Total non current assets
-5.83%6.2B
-8.91%6.23B
-7.03%6.42B
-7.09%6.46B
-15.69%6.58B
-17.97%6.84B
-16.56%6.9B
-8.61%6.95B
-12.97%7.8B
-6.44%8.33B
Total assets
-4.90%8.05B
-4.44%8.12B
-4.21%8.24B
-4.18%8.28B
-9.27%8.47B
-22.37%8.49B
-22.99%8.6B
-19.15%8.64B
-19.78%9.33B
-5.72%10.94B
Liabilities
Current liabilities
Short term loan
-4.45%1.44B
-3.58%1.45B
-24.49%1.49B
-22.22%1.5B
-18.37%1.51B
-39.25%1.51B
-21.52%1.98B
-21.90%1.93B
-11.25%1.85B
2.72%2.48B
Notes payable and accounts payable
11.68%1.17B
13.86%1.17B
9.31%1.1B
9.94%1.09B
40.35%1.05B
7.38%1.03B
-2.59%1.01B
-23.92%988.95M
-27.52%748.71M
6.47%959.01M
-Notes payable
-97.19%258.23K
-94.68%570.63K
-95.76%518.22K
-86.17%2.48M
167.95%9.19M
1,686.76%10.73M
13.28%12.21M
85.21%17.95M
-98.54%3.43M
-99.52%600.3K
-Accounts payable
12.64%1.17B
15.00%1.17B
10.59%1.1B
11.72%1.08B
39.76%1.04B
6.32%1.02B
-2.76%996.23M
-24.74%971M
-6.54%745.28M
23.41%958.41M
Contract liabilities
49.05%151.95M
10.07%138.98M
-21.17%138.3M
-35.24%161.24M
35.17%101.95M
49.43%126.27M
139.15%175.43M
112.11%248.99M
-24.01%75.42M
-9.08%84.5M
Advance receipts
----
--0
--0
96.21%1.57M
----
----
----
--798.17K
----
----
Salaries payable
-7.90%39.12M
-12.86%34M
-7.89%33.59M
29.93%44.54M
27.88%42.48M
12.51%39.02M
26.16%36.47M
-1.86%34.28M
25.48%33.22M
34.66%34.68M
Taxs payable
-6.99%53.12M
-0.12%50.29M
93.19%66.66M
110.22%70.63M
121.02%57.11M
97.21%50.35M
29.79%34.5M
5.17%33.6M
78.80%25.84M
41.98%25.53M
Other payable (including interest and dividends)
8.05%1.95B
10.82%1.93B
6.61%1.87B
3.33%1.86B
-28.05%1.8B
-32.33%1.75B
-32.01%1.75B
-2.53%1.8B
-5.76%2.5B
7.29%2.58B
-Interest payable
--71.51M
--41.04M
----
----
----
----
----
----
----
----
-Dividend payable
----
----
----
----
----
----
----
--15.67M
-39.35%15.67M
-39.35%15.67M
-Other payable
----
--1.89B
----
----
----
----
----
--1.79B
----
7.79%2.56B
Hold and for sell liabilities
-10.47%31.55M
-5.13%31.33M
-7.97%29.96M
-29.99%26.21M
3.69%35.24M
-9.00%33.02M
-20.92%32.55M
-57.84%37.43M
7.96%33.99M
-3.04%36.29M
Non current liabilities due within one year
135.18%277.83M
133.67%365.04M
335.04%343.34M
330.08%343.95M
-49.44%118.13M
-47.23%156.22M
-76.92%78.92M
-82.25%79.97M
15.39%233.66M
66.85%296.05M
Other current liabilities
-52.09%41.12M
-52.51%45.25M
-13.76%77.64M
-18.40%65.68M
963.21%85.83M
978.50%95.27M
904.16%90.02M
426.71%80.49M
-26.06%8.07M
-23.69%8.83M
Total current liabilities
7.38%5.16B
9.25%5.22B
-0.64%5.15B
-1.37%5.16B
-12.87%4.8B
-26.48%4.78B
-22.05%5.19B
-17.64%5.23B
-10.50%5.51B
6.94%6.5B
Current liabilities
Long term loan
-29.05%578.49M
-36.84%492.89M
28.26%547.27M
30.23%556M
59.97%815.39M
43.20%780.44M
-30.77%426.68M
-19.28%426.93M
-19.51%509.71M
-16.04%544.98M
Long term account payable
----
--0
----
----
----
----
----
--0
----
--0
Specific account payable
----
--75.51M
----
----
----
----
----
--120.43M
----
62.53%124.13M
Estimate liabilities
-64.04%23.09M
-53.75%27.43M
-43.89%28.78M
-44.03%27.78M
43.36%64.22M
32.38%59.3M
209.33%51.29M
199.33%49.63M
--44.8M
3.54%44.8M
Deferred tax liabilities
--8.84M
--9.25M
--9.46M
42.90%9.46M
----
----
----
77.64%6.62M
721.40%5.24M
508.73%5.41M
Long term deferred income
2.78%61.04M
0.00%60.42M
-3.63%60.94M
0.12%60.42M
-2.42%59.39M
-8.86%60.41M
13.62%63.23M
-8.07%60.35M
-20.92%60.86M
-14.31%66.28M
Lease liabilities
162.26%33.9M
46.16%33.81M
44.56%32.29M
40.13%34.92M
1,361.56%12.93M
1,270.10%23.13M
882.14%22.34M
956.45%24.92M
--884.54K
89.74%1.69M
Total non current liabilities
-27.81%780.87M
-33.60%699.31M
15.82%802.68M
16.96%805.73M
44.89%1.08B
33.77%1.05B
-13.57%693.07M
1.53%688.88M
-26.68%746.59M
-26.79%787.29M
Total liabilities
0.91%5.94B
1.52%5.92B
1.30%5.96B
0.77%5.97B
-5.98%5.88B
-19.97%5.83B
-21.14%5.88B
-15.79%5.92B
-12.80%6.26B
1.87%7.29B
Shareholders equity
Paid-in capital
0.00%661.28M
0.00%661.28M
0.00%661.28M
0.00%661.28M
0.00%661.28M
0.00%661.28M
-0.01%661.28M
-0.01%661.28M
-0.01%661.28M
-0.01%661.28M
Capital reserve funds
0.00%2.15B
0.00%2.15B
0.00%2.15B
0.00%2.15B
0.00%2.15B
0.00%2.15B
-0.01%2.15B
-0.01%2.15B
-0.22%2.15B
-0.13%2.15B
Surplus reserve funds
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
0.00%105.37M
Retained profit
-61.82%-1.21B
-68.89%-1.12B
-72.19%-1.02B
-64.99%-987.43M
-180.40%-744.79M
-383.72%-664.71M
-2,684.58%-594.18M
-774.80%-598.47M
-136.03%-265.62M
-117.83%-137.42M
Less:Treasury stock
0.00%8.5M
0.00%8.5M
0.00%8.5M
0.00%8.5M
0.00%8.5M
0.00%8.5M
-3.12%8.5M
-3.12%8.5M
-57.73%8.5M
-57.73%8.5M
Other composite income
120.44%1.63M
122.70%1.79M
117.72%1.7M
132.60%1.69M
-311.36%-7.96M
-389.91%-7.9M
-600.37%-9.58M
-351.09%-5.19M
-23.22%3.77M
-31.43%2.72M
Shareholders equity without minority interests
-20.90%1.71B
-20.03%1.79B
-18.11%1.89B
-16.56%1.92B
-18.53%2.16B
-19.38%2.24B
-20.21%2.31B
-18.89%2.31B
-27.35%2.65B
-24.50%2.78B
Minority interests
-4.07%409.84M
-4.13%403.28M
-5.00%395.97M
-5.98%388.52M
-0.11%427.23M
-51.89%420.65M
-49.46%416.79M
-49.12%413.22M
-47.48%427.69M
13.41%874.37M
Total shareholder equity
-18.11%2.12B
-17.51%2.19B
-16.10%2.29B
-14.96%2.31B
-15.97%2.58B
-27.17%2.66B
-26.70%2.72B
-25.61%2.72B
-31.03%3.08B
-17.93%3.65B
Total liabilityies and equity
-4.90%8.05B
-4.44%8.12B
-4.21%8.24B
-4.18%8.28B
-9.27%8.47B
-22.37%8.49B
-22.99%8.6B
-19.15%8.64B
-19.78%9.33B
-5.72%10.94B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Beijing Dahua International Accounting Firm (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -42.27%75.6M-19.70%102.35M-17.99%117.27M-10.32%149.32M-21.56%130.96M-40.93%127.45M-59.93%142.99M-15.10%166.5M1.30%166.96M0.50%215.76M
Transactional financial assets --------7,158.71%4M-------------99.91%55.11K-99.81%125.98K-92.50%231.17K1,509.86%75.89M
Notes receivable and accounts receivable 10.89%891.32M10.98%862.15M13.41%832.14M16.45%793.8M46.85%803.78M-31.13%776.82M-37.00%733.77M-38.54%681.65M-51.41%547.36M2.42%1.13B
-Notes receivable -73.72%39.76M-66.29%48.7M-33.32%87.45M8.81%88.86M5,546.15%151.28M1,149.32%144.47M--131.16M555.27%81.66M--2.68M--11.56M
-Accounts receivable 30.51%851.57M28.64%813.45M23.58%744.69M17.49%704.94M19.80%652.5M-43.36%632.35M-48.26%602.61M-45.29%599.99M-51.65%544.68M1.37%1.12B
Other receivables (including interest and dividends) 19.75%64.91M7.21%59.55M-20.76%51.78M-31.28%52.55M-23.80%54.21M22.38%55.55M-15.14%65.35M-77.90%76.47M-31.38%71.14M-59.74%45.39M
-Dividend receivable --22.44M--22.44M--22.44M0.00%22.44M--------------22.44M--------
-Other receivable ------37.11M----------------------54.03M-----46.51%45.39M
Advance payment -4.51%21.63M-26.83%21.78M-30.12%27.21M-55.08%24.55M-54.42%22.65M8.09%29.77M-59.42%38.93M-28.10%54.66M-18.85%49.69M-55.41%27.54M
Inventories -16.63%420.98M-5.75%462.58M-19.71%407.6M-11.94%411.3M18.25%504.96M-27.25%490.78M-28.45%507.63M-38.66%467.07M-50.43%427.03M-20.65%674.65M
Receivable financing ------0-----96.79%642.66K-95.45%2.34M-88.37%7.9M-90.06%8.04M-81.98%20.05M-23.26%51.43M-13.34%67.87M
Assets held for sale 8.07%314.7M251.06%312.78M168.80%311.56M133.79%323.74M128.40%291.2M-12.36%89.1M8.99%115.91M-30.39%138.48M-9.48%127.5M-30.17%101.66M
Other current assets -12.90%68.42M-14.54%68.48M-17.84%72.22M-22.38%68.45M-11.26%78.55M-70.47%80.12M-64.74%87.9M-60.16%88.18M-36.78%88.51M111.72%271.35M
Total current assets -1.65%1.86B14.01%1.89B7.24%1.82B7.75%1.82B23.45%1.89B-36.45%1.66B-41.34%1.7B-45.13%1.69B-42.67%1.53B-3.32%2.61B
Non Current assets
Other equity investment -2.76%86.53M-2.76%86.53M-2.76%86.53M-2.76%86.53M-10.10%88.98M-10.10%88.98M-10.10%88.98M-10.10%88.98M-67.33%98.98M-62.36%98.98M
Other non-current financial assets -36.25%29.29M-18.50%38.58M1.97%48.27M1.89%48.24M-14.69%45.95M-13.96%47.33M-15.39%47.34M-16.10%47.35M-49.86%53.86M-48.81%55.01M
Investment real estate ------------------------------------11.84%245.3M
Long-term equity investment -68.32%33.92M-88.97%34.03M-86.87%44.18M-86.98%43.71M-67.52%107.08M178.97%308.47M201.41%336.38M192.43%335.7M171.80%329.72M-11.44%110.57M
Fixed assets ------3.28B----------------------3.6B----100.20%4B
Constru in process ------1.13B----------------------1.18B-----47.78%2B
Productive biological assets 14.64%616.77K-3.87%648.91K-3.04%609.25K-3.24%560.59K1.41%538K-17.83%675K-22.08%628.35K-27.05%579.35K-31.77%530.51K7.32%821.5K
Intangible assets -8.33%851.89M-7.69%868.69M-4.67%907.42M-4.65%919.28M-4.70%929.27M-6.92%941.05M-7.54%951.92M-6.79%964.09M-8.20%975.11M-5.58%1.01B
Development expenditure 8.66%459.2M8.32%450.44M8.83%445.5M8.33%436.49M7.79%422.59M0.85%415.85M0.92%409.34M1.89%402.93M-5.60%392.07M1.79%412.35M
Goodwill 0.00%199.72M0.00%199.72M0.00%199.72M0.00%199.72M0.00%199.72M-25.09%199.72M-25.09%199.72M-25.09%199.72M-68.13%199.72M-57.45%266.6M
Long deferred expense -8.51%34.2M-3.73%36.45M2.80%38.19M6.86%40.31M9.38%37.38M28.62%37.86M18.03%37.15M10.76%37.72M-5.96%34.17M-20.97%29.43M
Deferred tax assets -5.12%25.21M-0.34%28.4M8.94%28.72M-14.79%28.42M74.71%26.57M58.43%28.5M36.59%26.37M72.14%33.35M-24.00%15.21M-11.66%17.99M
Usufruct assets 36.45%31.91M39.86%33.94M39.31%35.35M36.55%36.16M1,313.63%23.39M529.46%24.27M458.67%25.38M399.97%26.48M-1.32%1.65M59.53%3.86M
Other non current assets -30.31%23.76M11.90%38.48M31.86%38.87M6.87%33.08M-56.13%34.1M-60.70%34.39M-53.26%29.48M-55.45%30.95M-61.42%77.73M-58.00%87.51M
Total non current assets -5.83%6.2B-8.91%6.23B-7.03%6.42B-7.09%6.46B-15.69%6.58B-17.97%6.84B-16.56%6.9B-8.61%6.95B-12.97%7.8B-6.44%8.33B
Total assets -4.90%8.05B-4.44%8.12B-4.21%8.24B-4.18%8.28B-9.27%8.47B-22.37%8.49B-22.99%8.6B-19.15%8.64B-19.78%9.33B-5.72%10.94B
Liabilities
Current liabilities
Short term loan -4.45%1.44B-3.58%1.45B-24.49%1.49B-22.22%1.5B-18.37%1.51B-39.25%1.51B-21.52%1.98B-21.90%1.93B-11.25%1.85B2.72%2.48B
Notes payable and accounts payable 11.68%1.17B13.86%1.17B9.31%1.1B9.94%1.09B40.35%1.05B7.38%1.03B-2.59%1.01B-23.92%988.95M-27.52%748.71M6.47%959.01M
-Notes payable -97.19%258.23K-94.68%570.63K-95.76%518.22K-86.17%2.48M167.95%9.19M1,686.76%10.73M13.28%12.21M85.21%17.95M-98.54%3.43M-99.52%600.3K
-Accounts payable 12.64%1.17B15.00%1.17B10.59%1.1B11.72%1.08B39.76%1.04B6.32%1.02B-2.76%996.23M-24.74%971M-6.54%745.28M23.41%958.41M
Contract liabilities 49.05%151.95M10.07%138.98M-21.17%138.3M-35.24%161.24M35.17%101.95M49.43%126.27M139.15%175.43M112.11%248.99M-24.01%75.42M-9.08%84.5M
Advance receipts ------0--096.21%1.57M--------------798.17K--------
Salaries payable -7.90%39.12M-12.86%34M-7.89%33.59M29.93%44.54M27.88%42.48M12.51%39.02M26.16%36.47M-1.86%34.28M25.48%33.22M34.66%34.68M
Taxs payable -6.99%53.12M-0.12%50.29M93.19%66.66M110.22%70.63M121.02%57.11M97.21%50.35M29.79%34.5M5.17%33.6M78.80%25.84M41.98%25.53M
Other payable (including interest and dividends) 8.05%1.95B10.82%1.93B6.61%1.87B3.33%1.86B-28.05%1.8B-32.33%1.75B-32.01%1.75B-2.53%1.8B-5.76%2.5B7.29%2.58B
-Interest payable --71.51M--41.04M--------------------------------
-Dividend payable ------------------------------15.67M-39.35%15.67M-39.35%15.67M
-Other payable ------1.89B----------------------1.79B----7.79%2.56B
Hold and for sell liabilities -10.47%31.55M-5.13%31.33M-7.97%29.96M-29.99%26.21M3.69%35.24M-9.00%33.02M-20.92%32.55M-57.84%37.43M7.96%33.99M-3.04%36.29M
Non current liabilities due within one year 135.18%277.83M133.67%365.04M335.04%343.34M330.08%343.95M-49.44%118.13M-47.23%156.22M-76.92%78.92M-82.25%79.97M15.39%233.66M66.85%296.05M
Other current liabilities -52.09%41.12M-52.51%45.25M-13.76%77.64M-18.40%65.68M963.21%85.83M978.50%95.27M904.16%90.02M426.71%80.49M-26.06%8.07M-23.69%8.83M
Total current liabilities 7.38%5.16B9.25%5.22B-0.64%5.15B-1.37%5.16B-12.87%4.8B-26.48%4.78B-22.05%5.19B-17.64%5.23B-10.50%5.51B6.94%6.5B
Current liabilities
Long term loan -29.05%578.49M-36.84%492.89M28.26%547.27M30.23%556M59.97%815.39M43.20%780.44M-30.77%426.68M-19.28%426.93M-19.51%509.71M-16.04%544.98M
Long term account payable ------0----------------------0------0
Specific account payable ------75.51M----------------------120.43M----62.53%124.13M
Estimate liabilities -64.04%23.09M-53.75%27.43M-43.89%28.78M-44.03%27.78M43.36%64.22M32.38%59.3M209.33%51.29M199.33%49.63M--44.8M3.54%44.8M
Deferred tax liabilities --8.84M--9.25M--9.46M42.90%9.46M------------77.64%6.62M721.40%5.24M508.73%5.41M
Long term deferred income 2.78%61.04M0.00%60.42M-3.63%60.94M0.12%60.42M-2.42%59.39M-8.86%60.41M13.62%63.23M-8.07%60.35M-20.92%60.86M-14.31%66.28M
Lease liabilities 162.26%33.9M46.16%33.81M44.56%32.29M40.13%34.92M1,361.56%12.93M1,270.10%23.13M882.14%22.34M956.45%24.92M--884.54K89.74%1.69M
Total non current liabilities -27.81%780.87M-33.60%699.31M15.82%802.68M16.96%805.73M44.89%1.08B33.77%1.05B-13.57%693.07M1.53%688.88M-26.68%746.59M-26.79%787.29M
Total liabilities 0.91%5.94B1.52%5.92B1.30%5.96B0.77%5.97B-5.98%5.88B-19.97%5.83B-21.14%5.88B-15.79%5.92B-12.80%6.26B1.87%7.29B
Shareholders equity
Paid-in capital 0.00%661.28M0.00%661.28M0.00%661.28M0.00%661.28M0.00%661.28M0.00%661.28M-0.01%661.28M-0.01%661.28M-0.01%661.28M-0.01%661.28M
Capital reserve funds 0.00%2.15B0.00%2.15B0.00%2.15B0.00%2.15B0.00%2.15B0.00%2.15B-0.01%2.15B-0.01%2.15B-0.22%2.15B-0.13%2.15B
Surplus reserve funds 0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M0.00%105.37M
Retained profit -61.82%-1.21B-68.89%-1.12B-72.19%-1.02B-64.99%-987.43M-180.40%-744.79M-383.72%-664.71M-2,684.58%-594.18M-774.80%-598.47M-136.03%-265.62M-117.83%-137.42M
Less:Treasury stock 0.00%8.5M0.00%8.5M0.00%8.5M0.00%8.5M0.00%8.5M0.00%8.5M-3.12%8.5M-3.12%8.5M-57.73%8.5M-57.73%8.5M
Other composite income 120.44%1.63M122.70%1.79M117.72%1.7M132.60%1.69M-311.36%-7.96M-389.91%-7.9M-600.37%-9.58M-351.09%-5.19M-23.22%3.77M-31.43%2.72M
Shareholders equity without minority interests -20.90%1.71B-20.03%1.79B-18.11%1.89B-16.56%1.92B-18.53%2.16B-19.38%2.24B-20.21%2.31B-18.89%2.31B-27.35%2.65B-24.50%2.78B
Minority interests -4.07%409.84M-4.13%403.28M-5.00%395.97M-5.98%388.52M-0.11%427.23M-51.89%420.65M-49.46%416.79M-49.12%413.22M-47.48%427.69M13.41%874.37M
Total shareholder equity -18.11%2.12B-17.51%2.19B-16.10%2.29B-14.96%2.31B-15.97%2.58B-27.17%2.66B-26.70%2.72B-25.61%2.72B-31.03%3.08B-17.93%3.65B
Total liabilityies and equity -4.90%8.05B-4.44%8.12B-4.21%8.24B-4.18%8.28B-9.27%8.47B-22.37%8.49B-22.99%8.6B-19.15%8.64B-19.78%9.33B-5.72%10.94B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Reservations with explanatory notes------Unqualified opinion----
Auditor ------Beijing Dahua International Accounting Firm (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data